SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 118 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,678,000 | +25.5% | 11,046 | -1.5% | 0.00% | +33.3% |
| Q1 2019 | $1,337,000 | +9.5% | 11,215 | +0.2% | 0.00% | -25.0% |
| Q4 2018 | $1,221,000 | -23.4% | 11,191 | +13.4% | 0.00% | 0.0% |
| Q3 2018 | $1,594,000 | +27.5% | 9,871 | +4.4% | 0.00% | +33.3% |
| Q2 2018 | $1,250,000 | +78.6% | 9,454 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $700,000 | +209.7% | 9,454 | -44.4% | 0.00% | +100.0% |
| Q1 2015 | $226,000 | -63.7% | 16,990 | -60.5% | 0.00% | -50.0% |
| Q4 2014 | $623,000 | -31.4% | 43,030 | 0.0% | 0.00% | -33.3% |
| Q3 2014 | $908,000 | -29.2% | 43,030 | 0.0% | 0.00% | -40.0% |
| Q2 2014 | $1,282,000 | +24.0% | 43,030 | 0.0% | 0.01% | +25.0% |
| Q1 2014 | $1,034,000 | +71.8% | 43,030 | +45.7% | 0.00% | +100.0% |
| Q4 2013 | $602,000 | -56.8% | 29,530 | 0.0% | 0.00% | -66.7% |
| Q3 2013 | $1,395,000 | +48.9% | 29,530 | +19.9% | 0.01% | +50.0% |
| Q2 2013 | $937,000 | – | 24,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |